Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palisade Bio (PALI) Invested Capital (2016 - 2025)

Palisade Bio has reported Invested Capital over the past 16 years, most recently at $129.4 million for Q4 2025.

  • Quarterly Invested Capital rose 1626.91% to $129.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $129.4 million through Dec 2025, up 1626.91% year-over-year, with the annual reading at $129.4 million for FY2025, 1626.91% up from the prior year.
  • Invested Capital was $129.4 million for Q4 2025 at Palisade Bio, up from $3.4 million in the prior quarter.
  • Over five years, Invested Capital peaked at $129.4 million in Q4 2025 and troughed at -$20.1 million in Q1 2021.
  • The 5-year median for Invested Capital is $7.5 million (2021), against an average of $12.4 million.
  • Year-over-year, Invested Capital tumbled 96.14% in 2021 and then surged 1626.91% in 2025.
  • A 5-year view of Invested Capital shows it stood at $7.5 million in 2021, then soared by 67.46% to $12.5 million in 2022, then decreased by 8.2% to $11.5 million in 2023, then tumbled by 34.6% to $7.5 million in 2024, then surged by 1626.91% to $129.4 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Invested Capital are $129.4 million (Q4 2025), $3.4 million (Q3 2025), and $2.7 million (Q2 2025).